Citigroup’s First Trust NYSE Arca Biotechnology Index Fund FBT Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $3.37M | Sell |
13,604
-163
| -1% | -$35.1K | ﹤0.01% | 2490 |
|
|
2026
Q1 | $2.76M | Sell |
13,767
-73
| -0.5% | -$15.1K | ﹤0.01% | 2441 |
|
|
2025
Q4 | $2.86M | Buy |
13,840
+1,002
| +8% | +$200K | ﹤0.01% | 2418 |
|
|
2025
Q3 | $2.3M | Buy |
12,838
+677
| +6% | +$115K | ﹤0.01% | 2562 |
|
|
2025
Q2 | $1.96M | Sell |
12,161
-453
| -4% | -$72.2K | ﹤0.01% | 2664 |
|
|
2025
Q1 | $2.15M | Sell |
12,614
-1,872
| -13% | -$325K | ﹤0.01% | 2636 |
|
|
2024
Q4 | $2.41M | Sell |
14,486
-4,576
| -24% | -$782K | ﹤0.01% | 2657 |
|
|
2024
Q3 | $3.28M | Sell |
19,062
-1,045
| -5% | -$173K | ﹤0.01% | 2215 |
|
|
2024
Q2 | $3.1M | Buy |
20,107
+4,564
| +29% | +$685K | ﹤0.01% | 1996 |
|
|
2024
Q1 | $2.39M | Buy |
15,543
+3,121
| +25% | +$476K | ﹤0.01% | 2296 |
|
|
2023
Q4 | $1.96M | Sell |
12,422
-1,552
| -11% | -$223K | ﹤0.01% | 2254 |
|
|
2023
Q3 | $2.05M | Buy |
13,974
+1,607
| +13% | +$245K | ﹤0.01% | 1964 |
|
|
2023
Q2 | $1.89M | Buy |
12,367
+224
| +2% | +$34.9K | ﹤0.01% | 2268 |
|
|
2023
Q1 | $1.88M | Sell |
12,143
-561
| -4% | -$88.1K | ﹤0.01% | 2062 |
|
|
2022
Q4 | $1.96M | Sell |
12,704
-3,008
| -19% | -$444K | ﹤0.01% | 2055 |
|
|
2022
Q3 | $2.07M | Sell |
15,712
-911
| -5% | -$128K | ﹤0.01% | 2115 |
|
|
2022
Q2 | $2.25M | Sell |
16,623
-772
| -4% | -$106K | ﹤0.01% | 2019 |
|
|
2022
Q1 | $2.59M | Buy |
17,395
+33
| +0.2% | +$4.88K | ﹤0.01% | 2154 |
|
|
2021
Q4 | $2.81M | Buy |
17,362
+842
| +5% | +$136K | ﹤0.01% | 2332 |
|
|
2021
Q3 | $2.74M | Sell |
16,520
-8,470
| -34% | -$1.45M | ﹤0.01% | 2284 |
|
|
2021
Q2 | $4.31M | Buy |
24,990
+493
| +2% | +$81.4K | ﹤0.01% | 2022 |
|
|
2021
Q1 | $3.93M | Buy |
24,497
+798
| +3% | +$137K | ﹤0.01% | 1968 |
|
|
2020
Q4 | $3.98M | Buy |
23,699
+1,655
| +8% | +$268K | ﹤0.01% | 2257 |
|
|
2020
Q3 | $3.47M | Sell |
22,044
-522
| -2% | -$85.3K | ﹤0.01% | 2172 |
|
|
2020
Q2 | $3.79M | Buy |
22,566
+522
| +2% | +$81.9K | ﹤0.01% | 2126 |
|
|
2020
Q1 | $2.89M | Sell |
22,044
-2,049
| -9% | -$292K | ﹤0.01% | 2134 |
|
|
2019
Q4 | $3.58M | Sell |
24,093
-2,957
| -11% | -$406K | ﹤0.01% | 2338 |
|
|
2019
Q3 | $3.35M | Sell |
27,050
-1,742
| -6% | -$232K | ﹤0.01% | 2313 |
|
|
2019
Q2 | $4.05M | Buy |
28,792
+2,399
| +9% | +$331K | ﹤0.01% | 2154 |
|
|
2019
Q1 | $3.98M | Buy |
26,393
+868
| +3% | +$125K | ﹤0.01% | 1990 |
|
|
2018
Q4 | $3.17M | Buy |
25,525
+2,263
| +10% | +$309K | ﹤0.01% | 2254 |
|
|
2018
Q3 | $3.69M | Buy |
23,262
+5,178
| +29% | +$784K | ﹤0.01% | 2154 |
|
|
2018
Q2 | $2.53M | Buy |
18,084
+1,800
| +11% | +$247K | ﹤0.01% | 2482 |
|
|
2018
Q1 | $2.16M | Buy |
16,284
+3,087
| +23% | +$421K | ﹤0.01% | 2521 |
|
|
2017
Q4 | $1.64M | Buy |
13,197
+987
| +8% | +$122K | ﹤0.01% | 2867 |
|
|
2017
Q3 | $1.51M | Buy |
12,210
+1,865
| +18% | +$221K | ﹤0.01% | 2944 |
|
|
2017
Q2 | $1.18M | Buy |
10,345
+718
| +7% | +$77.2K | ﹤0.01% | 3136 |
|
|
2017
Q1 | $1.01M | Buy |
9,627
+5,753
| +149% | +$577K | ﹤0.01% | 3195 |
|
|
2016
Q4 | $352K | Buy |
3,874
+669
| +21% | +$62.7K | ﹤0.01% | 4749 |
|
|
2016
Q3 | $320K | Buy |
3,205
+60
| +2% | +$5.89K | ﹤0.01% | 4296 |
|
|
2016
Q2 | $281K | Sell |
3,145
-3,825
| -55% | -$351K | ﹤0.01% | 4188 |
|
|
2016
Q1 | $611K | Sell |
6,970
-22,584
| -76% | -$1.99M | ﹤0.01% | 3908 |
|
|
2015
Q4 | $3.34M | Buy |
29,554
+3,756
| +15% | +$404K | ﹤0.01% | 2067 |
|
|
2015
Q3 | $2.61M | Buy |
25,798
+5,355
| +26% | +$637K | ﹤0.01% | 2221 |
|
|
2015
Q2 | $2.54M | Buy |
20,443
+8,978
| +78% | +$1.08M | ﹤0.01% | 2311 |
|
|
2015
Q1 | $1.36M | Buy |
11,465
+6,463
| +129% | +$731K | ﹤0.01% | 2822 |
|
|
2014
Q4 | $510K | Buy |
5,002
+2,900
| +138% | +$283K | ﹤0.01% | 3869 |
|
|
2014
Q3 | $193K | Buy |
2,102
+359
| +21% | +$31.1K | ﹤0.01% | 4266 |
|
|
2014
Q2 | $144K | Buy |
1,743
+342
| +24% | +$26.1K | ﹤0.01% | 4393 |
|
|
2014
Q1 | $107K | Sell |
1,401
-1,488
| -52% | -$116K | ﹤0.01% | 4925 |
|
|
2013
Q4 | $200K | Buy |
2,889
+196
| +7% | +$12.9K | ﹤0.01% | 4657 |
|
|
2013
Q3 | $175K | Buy |
2,693
+2,276
| +546% | +$144K | ﹤0.01% | 4267 |
|
|
2013
Q2 | $24K | Buy |
+417
| New | +$23.8K | ﹤0.01% | 5744 |
|
Other funds holding FBT
BFG
Citigroup's FBT Position: Q2 2026 in Review
Citigroup reduced its First Trust NYSE Arca Biotechnology Index Fund (FBT) stake by 1.2% in Q2 2026, selling an estimated $35.1K and leaving 13,604 shares worth $3.37M. The position accounts for ﹤0.01% of the portfolio, ranked #2490.
Citigroup first reported a position in FBT in Q2 2013 and has held it in 53 quarters since. The position peaked at $4.31M in Q2 2021. 339 funds tracked by Wall St. Rank hold FBT as of Q2 2026.
- Citigroup held 13,604 shares of First Trust NYSE Arca Biotechnology Index Fund worth $3.37M as of Q2 2026.
- Citigroup sold 163 First Trust NYSE Arca Biotechnology Index Fund shares in Q2 2026, an estimated $35.1K.
- First Trust NYSE Arca Biotechnology Index Fund made up ﹤0.01% of Citigroup's portfolio in Q2 2026, its #2490 holding.
- Citigroup first reported a position in First Trust NYSE Arca Biotechnology Index Fund in Q2 2013 and has held it in 53 quarters since.
- Citigroup's First Trust NYSE Arca Biotechnology Index Fund position peaked at $4.31M in Q2 2021.
- 339 funds tracked by Wall St. Rank held First Trust NYSE Arca Biotechnology Index Fund as of Q2 2026.
Based on Citigroup's 13F filing for Q2 2026, filed 3 Aug 2026.